Abstract:Aims: To investigate the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP), Glomerular Filtration Rate (GFR), and outcomes in patients hospitalized with acute heart failure (AHF). Methods: The trial was registered at http://www.chictr.org/cn/. (ChiCTR - ONC - 12001944). A total of 493 patients hospitalized for AHF in cardiology department of the First Affiliated Hospital of Nanjing Medical University from March 2012 to October 2016 were enrolled into registry. The end event was the occurrence of all-cause death within an 18-month follow-up. The data collected from the participants in admission were used to calculate the GFR by chronic kidney disease epidemiology collaboration equation (CKD-EPI) and performed the according statistical analysis. Results: There were 74 participants (13.8%) dropped out and 91 (21.7%) passed away within the 18-month follow up. Comparison of clinical indicators between survival and death group were analyzed for the long-term prognosis of patients with AHF. In the single factor analysis, both NT-proBNP and GFR were statistically significant (P < 0.001). Combined NT-proBNP and GFR in multi-factor COX regression analysis showed significant predictive value (P < 0.001). In receiver operator characteristics (ROC) analyses, the area under the curves (AUC) for NT-proBNP was 0.648 [95%CI: 0.598-0.695, P < 0.001] and for GFR was 0.677 [95%CI: 0.627-0.723, P < 0.001]. According to the Youden index, the best prediction point of NT-proBNP was 2,137 pg/ml and GFR was 61.7 ml/(min·1.73 m2). After using the Binary Logistic Regression to combine the two indicators, the AUC was 0.711, which was significantly compared to the AUC of either single factor. The sensitivity of the combined indicators were 0.535, the specificity were 0.853. According to the cut-off point, these two indexes were separated into four groups for further analysis by Kaplan-Meier survival curve comparison (log-rank test), which showed that patients in the group with higher NT-proBNP and lower GFR had the worst prognosis. Conclusions: In patients with NT-proBNP > 2,137 pg/ml and GFR < 61.7 ml/(min·1.73 m2), the risk of death was significantly higher. The combination of GFR and NT-proBNP improved the predictive value for the long-term prognosis of AHF patients.

Results of five-year follow-up for hospitalization events according to level of B-type natriuretic peptide in aged patients with stable coronary heart disease

Correlation Between B Type Natriuretic Peptide And Metabolic Risk Factors

BNP levels and its influencing factors in patients with acute coronary syndrome

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

An Elevated Level of BNP in Plasma is Related to the Development of Good Collateral Circulation in Coronary Artery Disease

Prognosis Value of Sequential B-type Natriuretic Peptide Measurements for Patients Hospitalized with Chronic Congestive Heart Failure

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Correlation Between Brain Natriuretic Peptide Levels and the Prognosis of Patients with Left Ventricular Diastolic Dysfunction.

Use of B-type Natriuretic Peptide in Evaluation of Early Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

Prognostic Potential of B -Type Natriuetic Peptide and Quality of Life in Patients with Chronic Heart Failure

Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation

One Year Follow-Up for the Effects of B-type Natriuretic Peptide Baseline Level on Cardiovascular Events in Elderly Patients with Stable Coronary Artery Disease Receiving Drug-Eluting Stent

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

B type natriuretic peptide apply for dignosis and treatment in patients with congestive heart failure

Influencing factors for plasma natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels in senior patients with heart failure

Study on the Relationship between Spontaneous Cerebral Hemorrhage and Serum B-type Brain Natriuretic Peptide

Values of plasma N-terminal pro-B-type natriuretic peptide in severity assessment and prognostic prediction for chronic heart failure in the elderly

B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure

The Guidance Value and Prognostic Influence of Serum BNP Monitoring in Patients with Chronic Heart Failure

Clinical significance of plasma BNP in the evaluation of AECOPD

B-type natriuretic peptide and platelet parameters change in patients with chronic heart failure